Jianping Jia1, Cuibai Wei2, Shuoqi Chen3, Fangyu Li3, Yi Tang3, Wei Qin3, Lina Zhao3, Hongmei Jin3, Hui Xu3, Fen Wang3, Aihong Zhou3, Xiumei Zuo3, Liyong Wu3, Ying Han3, Yue Han3, Liyuan Huang3, Qi Wang3, Dan Li3, Changbiao Chu3, Lu Shi3, Min Gong3, Yifeng Du4, Jiewen Zhang5, Junjian Zhang6, Chunkui Zhou7, Jihui Lv8, Yang Lv9, Haiqun Xie10, Yong Ji11, Fang Li12, Enyan Yu13, Benyan Luo14, Yanjiang Wang15, Shanshan Yang16, Qiumin Qu17, Qihao Guo18, Furu Liang19, Jintao Zhang20, Lan Tan21, Lu Shen22, Kunnan Zhang23, Jinbiao Zhang24, Dantao Peng25, Muni Tang26, Peiyuan Lv27, Boyan Fang28, Lan Chu29, Longfei Jia30, Serge Gauthier31. 1. Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China; Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China; Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China; National Clinical Research Center for Geriatric Disorders, Beijing, China. Electronic address: jjp@ccmu.edu.cn. 2. Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China. Electronic address: chuibainews@126.com. 3. Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China. 4. Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, China. 5. Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China. 6. Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China. 7. Department of Neurology, The First Teaching Hospital of Jilin University, Changchun, China. 8. Dementia Unit, Beijing Geriatric Hospital, Beijing, China. 9. Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 10. Department of Neurology, Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China. 11. Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China. 12. Department of Gerontology, Fuxing Hospital, Capital Medical University, Beijing, China. 13. Department of Psychiatry, Zhejiang Provincial People's Hospital, Hangzhou, China. 14. Department of Neurology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China. 15. Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing, China. 16. Department of Neurology, Daqing Oilfield General Hospital, Daqing, China. 17. Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 18. Department of Neurology and Institute of Neurology, Huashan Hospital Fudan University, Shanghai, China. 19. Department of Neurology, Baotou Central Hospital, Baotou, China. 20. Department of Neurology, The 88th Hospital of PLA, Taian, China. 21. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China. 22. Department of Neurology, Xiangya Hospital Central South University, Changsha, China. 23. Department of Neurology, People's Hospital of Jiangxi Province, Nanchang, China. 24. Department of Neurology, Weihai Municipal Hospital, Weihai, China. 25. Department of Neurology, Center for Geriatric Medicine, China-Japan Friendship Hospital, Beijing, China. 26. Department of Geriatric Psychiatric, Guangzhou Huiai Hospital, Guangzhou, China. 27. Department of Neurology, Hebei General Hospital, Shijiazhuang, China. 28. Department of Neurology, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Beijing, China. 29. Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China. 30. Department of Neurology, Henry Ford Hospital, Detroit, MI, USA. 31. McGill Centre for Studies in Aging, McGill University, Montreal, Canada. Electronic address: serge.gauthier@mcgill.ca.
Abstract
INTRODUCTION: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain. METHODS: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD. RESULTS: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015. DISCUSSION: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.
INTRODUCTION: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain. METHODS: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD. RESULTS: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015. DISCUSSION: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.
Authors: Kunal P Patel; David T Wymer; Vinay K Bhatia; Ranjan Duara; Chetan D Rajadhyaksha Journal: Radiographics Date: 2020 Jan-Feb Impact factor: 5.333